MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.490
-0.010 (-0.22%)
Aug 31, 2026, 2:19 PM EDT - Market open

MiMedx Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
355.17418.63348.88321.48267.84242.02
Revenue Growth
-2.36%19.99%8.52%20.03%10.67%-2.50%
Gross Profit
280.05345.62288.81266.84219.53202.39
Operating Income
8.7563.8959.3137.12-14.73-7
Net Income
6.2448.5842.4246.59-36.78-16.42
Earnings Per Share
0.040.320.280.36-0.33-0.15
EPS Growth
-80.07%13.14%-22.18%---

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
135.84166.12104.428265.9587.08
Total Debt
17.2122.5324.8451.5552.4753.29
Net Cash (Debt)
118.63143.5979.5730.4613.4833.79
Net Cash Growth
18.15%80.45%161.28%125.96%-60.11%-23.17%
Net Cash Per Share
0.800.960.530.210.120.31

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
46.157466.226.78-17.89-1.98
Capital Expenditures
-1.65-1.03-1.68-1.99-1.51-3.22
Free Cash Flow
44.572.9764.5124.79-19.41-5.2
Free Cash Flow Growth
-22.11%13.11%160.27%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
78.85%82.56%82.78%83.00%81.96%83.63%
Operating Margin
2.46%15.26%17.00%11.54%-5.50%-2.89%
Pretax Margin
3.25%15.83%16.42%9.53%-7.37%-4.98%
Profit Margin
1.76%11.60%12.16%14.49%-13.73%-6.78%
FCF Margin
12.53%17.43%18.49%7.71%-7.25%-2.15%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
106.3420.6433.3321.91--
Forward PE
179.2021.6132.8935.0812.6712.67
P/FCF Ratio
14.6113.7421.9141.17--
PS Ratio
1.832.404.053.171.182.77